id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-E-2617-0006,FDA,FDA-2018-E-2617,Patent Term Extension Application Response Letter from FDA CDER to The Honorable Andrei Iancu,Other,Letter(s),2020-07-28T04:00:00Z,2020,7,2020-07-28T04:00:00Z,,2020-07-28T16:22:45Z,,0,0,09000064847ab791
FDA-2018-E-2617-0005,FDA,FDA-2018-E-2617,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2020-06-22T04:00:00Z,2020,6,2020-06-22T04:00:00Z,,2020-06-22T17:17:25Z,,0,0,09000064846feed7